Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis

20241 citationsJournal Articlediamond Open Access

Authors

Saurabh Ramdas Haral · Institute of Medical Sciences

Taskin Khan · Institute of Medical Sciences

Abstract

Eye drop interferon α-2b (1 million IU/ml) is a safe and effective option as first-line monotherapy for VKC. No side effects and recurrence were observed for 6 months.

Topics & Keywords

Ocular Surface and Contact Lens Ocular Infections and Treatments Corneal Surgery and Treatments

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Indian Journal of Ophthalmology

Volume 72, Issue 7, pp. 1007-1011

DOI: 10.4103/ijo.ijo_1393_23

Field-Weighted Citation Impact: 0.57